Advanced Cardiac Life Support ACLS Algorithms Drugs and Clinical Management Guide
medicine

Advanced Cardiac Life Support ACLS Algorithms Drugs and Clinical Management Guide

**Advanced Cardiac Life Support (ACLS)

Advanced Cardiac Life Support (ACLS) is a set of evidence-based clinical algorithms developed to manage adult cardiac arrest, peri-arrest conditions, and life-threatening cardiovascular emergencies. It builds upon Basic Life Support (BLS) and emphasizes high-quality CPR, early defibrillation, advanced airway management, pharmacology, and team-based resuscitation.


1. Goals of ACLS

  • Restore spontaneous circulation (ROSC)
  • Optimize oxygenation and perfusion
  • Identify and treat reversible causes
  • Minimize neurological injury
  • Improve survival with good neurological outcome

2. Core Principles of ACLS

High-Quality CPR

  • Rate: 100–120/min
  • Depth: 5–6 cm (2–2.4 inches)
  • Full chest recoil
  • Minimize interruptions (<10 seconds)
  • Compression-to-ventilation ratio:

* 30:2 (no advanced airway)

* Continuous compressions + 1 breath every 6 sec (advanced airway)

Early Defibrillation

  • Most effective for VF/pVT
  • Biphasic: 120–200 J
  • Monophasic: 360 J

Airway and Ventilation

  • Oxygen initially; titrate to SpO₂ 94–99% after ROSC
  • Advanced airway:

* Endotracheal tube

* Supraglottic airway

  • Confirm placement with capnography

* CPR quality marker: ETCO₂ ≥10 mmHg

* ROSC indicator: sudden ETCO₂ rise (>40 mmHg)


3. ACLS Cardiac Arrest Algorithms

A. Shockable Rhythm (VF / Pulseless VT)

  1. Start CPR → Attach defibrillator
  2. Shock #1
  3. CPR 2 min → IV/IO access
  4. Shock #2
  5. CPR + Epinephrine 1 mg IV/IO every 3–5 min
  6. Shock #3
  7. CPR + Amiodarone 300 mg IV bolus

* Second dose: 150 mg

  1. Continue cycles + treat Hs and Ts

B. Non-Shockable Rhythm (Asystole / PEA)

  1. CPR immediately
  2. IV/IO access
  3. Epinephrine 1 mg IV/IO every 3–5 min
  4. Reassess rhythm every 2 min
  5. Identify and treat reversible causes
  6. Defibrillation is NOT indicated

4. Reversible Causes – Hs and Ts

Hs

  • Hypoxia
  • Hypovolemia
  • Hydrogen ion (acidosis)
  • Hypo-/Hyperkalemia
  • Hypothermia

Ts

  • Tension pneumothorax
  • Tamponade (cardiac)
  • Toxins
  • Thrombosis (coronary)
  • Thrombosis (pulmonary)

5. Peri-Arrest Arrhythmia Management

A. Bradycardia (HR <50/min with symptoms)

Symptoms: hypotension, altered mental status, ischemia, shock

Management

  1. Atropine 1 mg IV every 3–5 min (max 3 mg)
  2. If ineffective:

* Transcutaneous pacing

* Dopamine infusion 5–20 mcg/kg/min

* Epinephrine infusion 2–10 mcg/min


B. Tachycardia (HR >150/min with pulse)

Step 1: Is the patient unstable?

  • Hypotension
  • Shock
  • Chest pain
  • Acute heart failure
  • Altered mental status

Immediate synchronized cardioversion


Step 2: Stable Tachycardia

##### Narrow QRS (<120 ms)

  • Regular: Adenosine 6 mg IV rapid push → 12 mg if needed
  • Irregular: Rate control (beta-blocker or calcium channel blocker)

##### Wide QRS (≥120 ms)

  • Monomorphic VT: Amiodarone 150 mg IV over 10 min
  • Polymorphic VT: Treat as VF (defibrillate)

6. ACLS Medications – Complete Drug Table

Epinephrine

  • Indication: Cardiac arrest, bradycardia infusion
  • Dose (arrest): 1 mg IV/IO every 3–5 min
  • MOA: α-vasoconstriction, β-inotropy
  • Adverse effects: Tachyarrhythmias, hypertension

Amiodarone

  • Indication: Refractory VF/pVT, VT with pulse
  • Dose (arrest): 300 mg IV bolus → 150 mg
  • MOA: Class III antiarrhythmic
  • Adverse effects: Hypotension, bradycardia

Lidocaine (alternative)

  • Dose: 1–1.5 mg/kg IV bolus
  • Use: If amiodarone unavailable

Atropine

  • Indication: Symptomatic bradycardia
  • Dose: 1 mg IV every 3–5 min (max 3 mg)
  • MOA: Anticholinergic → ↑ SA/AV node firing

Adenosine

  • Indication: Stable regular narrow-complex tachycardia
  • Dose: 6 mg IV rapid push → 12 mg
  • Contraindications: Asthma, irregular wide QRS

Magnesium Sulfate

  • Indication: Torsades de Pointes
  • Dose: 1–2 g IV over 5–20 min

7. Post–Cardiac Arrest Care

  • Maintain SpO₂ 94–99%
  • Avoid hypotension (MAP ≥65 mmHg)
  • Targeted Temperature Management (TTM):

* 32–36°C for 24 hours (if comatose)

  • Immediate 12-lead ECG
  • Coronary angiography if STEMI or suspected ischemia
  • Seizure control, glucose management

8. Termination of Resuscitation (TOR)

Consider when:

  • Persistent asystole despite optimal ACLS
  • No reversible causes
  • End-tidal CO₂ persistently <10 mmHg after 20 min
  • Medical futility and protocol compliance

9. ACLS Team Roles

  • Team leader
  • Compressor
  • Airway manager
  • Monitor/defibrillator operator
  • IV/IO medication nurse
  • Recorder/timekeeper

Effective ACLS requires closed-loop communication and role clarity.


10. Key ACLS Exam Pearls

  • Shock VF/pVT, not asystole/PEA
  • CPR quality > drugs
  • Epinephrine for all cardiac arrest rhythms
  • Amiodarone only after defibrillation
  • Treat cause, not just rhythm

Interactive MCQ Quiz

MCQ Exam Mode

15 Questions
Question 1 of 15

Frequently Asked Questions

Advanced Cardiac Life Support ACLS is a set of evidence based clinical protocols used to manage adult cardiac arrest, peri arrest conditions, and life threatening cardiovascular emergencies using algorithms, medications, airway management, and team based resuscitation.
The primary goals of ACLS are early return of spontaneous circulation, optimization of oxygenation and perfusion, identification and treatment of reversible causes, prevention of neurological injury, and improvement of survival outcomes.
The shockable rhythms in ACLS are ventricular fibrillation and pulseless ventricular tachycardia. These rhythms require immediate defibrillation.
Asystole and pulseless electrical activity are non shockable rhythms and are managed with high quality CPR, epinephrine, and treatment of reversible causes.
Epinephrine is used in all cardiac arrest rhythms to increase coronary and cerebral perfusion pressure through vasoconstriction and is given every 3 to 5 minutes during resuscitation.
Amiodarone is indicated for shock refractory ventricular fibrillation or pulseless ventricular tachycardia after defibrillation attempts and epinephrine administration.
The Hs and Ts are reversible causes of cardiac arrest. Hs include hypoxia, hypovolemia, hydrogen ion excess acidosis, hypo or hyperkalemia, and hypothermia. Ts include tension pneumothorax, cardiac tamponade, toxins, coronary thrombosis, and pulmonary thrombosis.
High quality CPR includes a compression rate of 100 to 120 per minute, depth of 5 to 6 cm, full chest recoil, minimal interruptions, and avoidance of excessive ventilation.
Capnography is used to confirm advanced airway placement, monitor CPR quality, and detect return of spontaneous circulation. An end tidal CO2 less than 10 mmHg suggests poor CPR quality.
Symptomatic bradycardia is initially treated with atropine. If atropine is ineffective, transcutaneous pacing or infusion of dopamine or epinephrine is recommended.
Synchronized cardioversion is used for unstable tachyarrhythmias with a pulse, including unstable supraventricular tachycardia and unstable ventricular tachycardia.
Targeted temperature management involves maintaining body temperature between 32 and 36 degrees Celsius in comatose patients after return of spontaneous circulation to reduce neurological injury.
Post cardiac arrest care focuses on optimizing oxygenation, maintaining adequate blood pressure, treating the underlying cause, preventing secondary brain injury, and improving long term survival.
Termination of resuscitation may be considered when there is prolonged resuscitation with no return of spontaneous circulation, no identifiable reversible causes, persistently low end tidal CO2, and adherence to ACLS protocols.
Effective team communication using closed loop communication improves coordination, reduces errors, and enhances the efficiency and success of resuscitation efforts.